Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,604 | -41,585 | -65,222 | -48,219 | -33,631 |
| Depreciation Amortization | 1,610 | 800 | 2,836 | 2,063 | 1,360 |
| Income taxes - deferred | 783 | 312 | 303 | N/A | 0 |
| Accounts receivable | -2,452 | -4,559 | -5,973 | -8,035 | -5,712 |
| Accounts payable and accrued liabilities | -2,549 | -698 | 2,970 | -823 | 867 |
| Other Working Capital | -4,058 | -8,980 | 4,606 | 3,451 | 3,419 |
| Other Operating Activity | 35,219 | 32,785 | 16,321 | 19,680 | 12,505 |
| Operating Cash Flow | $-27,051 | $-21,925 | $-44,159 | $-31,883 | $-21,192 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | N/A | N/A | 0 | -27,496 |
| PPE Investments | -581 | -307 | -2,890 | -2,468 | -2,318 |
| Net Acquisitions | N/A | N/A | -35,370 | N/A | N/A |
| Purchase Of Investment | -312 | -316 | 492 | 46 | 47 |
| Investing Cash Flow | $-893 | $-623 | $-37,768 | $-2,422 | $-29,767 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -6,000 | N/A |
| Debt Repayment | -6,000 | -3,000 | -9,000 | N/A | -3,000 |
| Common Stock Issued | 717 | 41 | 99,896 | 105,452 | 104,035 |
| Other Financing Activity | 0 | 0 | 0 | -6,375 | -6,277 |
| Financing Cash Flow | $-5,283 | $-2,959 | $90,896 | $93,077 | $94,758 |
| Exchange Rate Effect | 114 | 193 | -1,230 | -741 | -418 |
| Beginning Cash Position | 157,352 | 157,352 | 149,613 | 149,613 | 149,613 |
| End Cash Position | 124,239 | 132,038 | 157,352 | 207,644 | 192,994 |
| Net Cash Flow | $-33,113 | $-25,314 | $7,739 | $58,031 | $43,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,051 | -21,925 | -44,159 | -31,883 | -21,192 |
| Capital Expenditure | -581 | -307 | -2,890 | -2,468 | -2,318 |
| Free Cash Flow | -27,632 | -22,232 | -47,049 | -34,351 | -23,510 |